Frameless Single Robotic Radiosurgery for Pulmonary Metastases in Colorectal Cancer Patients

por Von Einem, Jobst C, Stintzing, Sebastian, Modest, Dominik P, Wiedemann, Michael, Fürweger, Christoph, Muacevic, Alexander
Publicado 2020

Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic C...

por Zöhrlaut, Linda Katharina, Karthaus, Meinolf, Vehling-Kaiser, Ursula, von Kunhardt, Lukas, Stintzing, Sebastian, Heinemann, Volker, von Einem, Jobst C.
Publicado 2023

Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

por Niess, Hanno, von Einem, Jobst C, Thomas, Michael N, Michl, Marlies, Angele, Martin K, Huss, Ralf, Günther, Christine, Nelson, Peter J, Bruns, Christiane J, Heinemann, Volker
Publicado 2015

Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials

por Stahler, Arndt, Heinemann, Volker, Ricard, Ingrid, von Einem, Jobst C., Giessen-Jung, Clemens, Westphalen, Christoph Benedikt, Michl, Marlies, Heinrich, Kathrin, Miller-Phillips, Lisa, Jelas, Ivan, Stintzing, Sebastian, Modest, Dominik Paul
Publicado 2020

In vivo monitoring of sorafenib therapy effects on experimental prostate carcinomas using dynamic contrast-enhanced MRI and macromolecular contrast media

por Cyran, Clemens C., Schwarz, Bettina, Paprottka, Philipp M., Sourbron, Steven, von Einem, Jobst C., Dietrich, Olaf, Hinkel, Rabea, Clevert, Dirk A., Bruns, Christiane J., Reiser, Maximilian F., Nikolaou, Konstantin, Wintersperger, Bernd J.
Publicado 2013

Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trial

por von Einem, Jobst C., Peter, Sylvia, Günther, Christine, Volk, Hans-Dieter, Grütz, Gerald, Salat, Christoph, Stoetzer, Oliver, Nelson, Peter J., Michl, Marlies, Modest, Dominik P., Holch, Julian W., Angele, Martin, Bruns, Christiane, Niess, Hanno, Heinemann, Volker
Publicado 2017

Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306

por Modest, Dominik Paul, Heinemann, Volker, Folprecht, Gunnar, Denecke, Timm, Pratschke, Johann, Lang, Hauke, Bemelmans, Marc, Becker, Thomas, Rentsch, Markus, Seehofer, Daniel, Bruns, Christiane J., Gebauer, Bernhard, Held, Swantje, Stahler, Arndt, Heinrich, Kathrin, von Einem, Jobst C., Stintzing, Sebastian, Neumann, Ulf P., Ricard, Ingrid
Publicado 2020

Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy

por Alig, Annabel H. S., Heinemann, Volker, Geissler, Michael, Fischer von Weikersthal, Ludwig, Decker, Thomas, Heinrich, Kathrin, Held, Swantje, Weiss, Lena, Fischer, Laura E., Moosmann, Nicolas, Stahler, Arndt, Jelas, Ivan, Kurreck, Annika, von Einem, Jobst C., Reinacher-Schick, Anke C., Tannapfel, Andrea, Giessen-Jung, Clemens, Stintzing, Sebastian, Modest, Dominik P.
Publicado 2022

Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy—Analysis of the Phase 3 XELAVIRI Trial

por Kurreck, Annika, Heinemann, Volker, Fischer von Weikersthal, Ludwig, Decker, Thomas, Kaiser, Florian, Uhlig, Jens, Schenk, Michael, Freiberg-Richter, Jens, Peuser, Bettina, Denzlinger, Claudio, Graeven, Ullrich, Heinrich, Kathrin, Held, Swantje, Stahler, Arndt, Alig, Annabel Helga Sophie, Jelas, Ivan, von Einem, Jobst C., Stintzing, Sebastian, Giessen-Jung, Clemens, Modest, Dominik P.
Publicado 2022